HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2.

Abstract
The mitochondrial permeability transition (MPT) mediates hepatic necrosis after ischemia and reperfusion (I/R). Here, we studied the role of c-Jun N-terminal kinase 2 (JNK2) in MPT-induced liver injury. Wildtype (WT) and JNK2 knockout (KO) mice underwent 70% liver ischemia for 1 hr followed by reperfusion for 8 hr, after which hepatocyte injury and animal survival was assessed. Compared with WT, JNK2 KO mice had 38% less alanine transaminase release and 39% less necrosis by histology. Survival out to 14 days was also greater in JNK2 KO mice (57% vs. 11%), and overall Kaplan-Meier survival was improved. No difference in apoptosis was observed. Intravital multiphoton microscopy of potential-indicating rhodamine 123 after reperfusion revealed depolarized mitochondria in 82% of WT hepatocytes, which decreased to 43% in JNK2 KO hepatocytes. In conclusion, JNK2 contributes to hepatocellular injury and death after I/R in association with increased mitochondrial dysfunction via the MPT.
AuthorsTom P Theruvath, Mark C Snoddy, Zhi Zhong, John J Lemasters
JournalTransplantation (Transplantation) Vol. 85 Issue 10 Pg. 1500-4 (May 27 2008) ISSN: 0041-1337 [Print] United States
PMID18497693 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Mitogen-Activated Protein Kinase 9
  • JNK Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Apoptosis
  • Intracellular Membranes (physiology)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Mice
  • Mice, Knockout
  • Mitochondria, Liver (physiology)
  • Mitochondrial Membranes (physiology)
  • Mitogen-Activated Protein Kinase 9 (deficiency, metabolism)
  • Permeability
  • Reperfusion Injury (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: